- Description
- Benefits
- Risks
- Additional information
- Research
Description
ARA-290 is a synthetic peptide derived from erythropoietin (EPO), specifically engineered for research into tissue protection, inflammatory response modulation, and cellular repair mechanisms without activating the erythropoietic (red blood cell production) pathways typically associated with EPO.
In laboratory settings, ARA-290 is studied for its interaction with the innate repair receptor (IRR), a receptor complex involved in tissue protection, anti-inflammatory signalling, and cellular recovery processes.
Due to its unique mechanism, ARA-290 has become a key compound in research peptide studies across Ireland and Europe, particularly in areas involving:
- Inflammatory pathway modulation
- Tissue protection and repair signalling
- Neurological and peripheral nerve research
- Cellular recovery and stress response models
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – ARA-290
| Specification | Details |
|---|---|
| Product Name | ARA-290 |
| Compound Type | Synthetic peptide (EPO-derived) |
| Functional Class | Tissue-protective research peptide |
| Mechanism of Action | Innate Repair Receptor (IRR) activation |
| Molecular Origin | Derived from erythropoietin structure |
| Biological Focus | Inflammation, tissue repair, nerve signalling |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – ARA-290
1. Anti-Inflammatory Pathway Research
ARA-290 has been studied for its potential role in:
- Modulating pro-inflammatory cytokine activity
- Reducing inflammatory signalling in tissue models
- Supporting immune response regulation research
Reference basis: Derived from preclinical and early clinical research investigating erythropoietin-derived peptides and inflammatory signalling pathways.
2. Tissue Protection & Cellular Repair
Research has explored ARA-290 in:
- Cellular protection under stress conditions
- Tissue repair and regeneration models
- Reduction of cellular damage in experimental systems
Reference basis: Supported by studies on innate repair receptor (IRR) activation and cytoprotective signalling mechanisms.
3. Neurological & Nerve Function Research
ARA-290 has been investigated for:
- Peripheral nerve repair models
- Neuropathic pathway research
- Neuroprotective signalling mechanisms
Reference basis: Based on experimental neuroscience and clinical research examining EPO-derived peptides in nerve and neurological studies.
4. Innate Repair Receptor (IRR) Activation
A key focus of ARA-290 research includes:
- Selective activation of the innate repair receptor
- Separation of tissue-protective effects from erythropoietic activity
- Exploration of targeted repair signalling pathways
Reference basis: Derived from biochemical and pharmacological studies examining IRR activation and receptor-specific peptide design.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – ARA-290
1. Limited Long-Term Data
- Research is still developing
- Limited long-term safety data
- Effects over extended periods remain uncertain
Reference basis: Reflects the current research stage of EPO-derived peptide compounds.
2. Immune System Interaction
Due to its mechanism:
- May influence immune and inflammatory pathways
- Potential for unintended immune modulation in models
Reference basis: Based on studies examining cytokine signalling and immune response pathways.
3. Off-Target Biological Effects
- Possible interaction with non-target receptors
- Broader influence across cell signalling systems
Reference basis: Derived from peptide-receptor interaction studies and systemic signalling research.
4. Experimental Compound Classification
- Not approved for medical or therapeutic use
- Requires controlled laboratory handling
- Strictly limited to research environments
Reference basis: Based on regulatory standards for research peptides in EU and international markets.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |
Related Products
FEATURED PRODUCTS
BEST SELLING PRODUCTS
LATEST PRODUCTS
TOP RATED PRODUCTS